OSI Systems Reports Fiscal 2024 Second Quarter Financial Results
- Record Q2 revenues of $373 million, a 26% growth year-over-year
- Record Q2 earnings per diluted share GAAP EPS of $2.11
- Non-GAAP Adjusted EPS of $2.21, an 86% growth year-over-year
- Q2 operating income growth of 105% year-over-year
- Company increases FY 2024 revenue and non-GAAP adjusted diluted EPS guidance
- Q2-Ended backlog of approximately $1.8 billion
- None.
Insights
The reported revenue and earnings growth for OSI Systems is a strong indicator of the company's operational efficiency and market demand for its products. The substantial year-over-year increase of 26% in revenues, coupled with an 86% growth in non-GAAP adjusted EPS, signifies not only improved profitability but also effective cost management and possibly favorable product mix or pricing power. The backlog of $1.8 billion provides a clear visibility into future revenues, which is a positive sign for investors looking for stability and growth prospects.
However, the negative operating cash flow of $23.5 million due to investments in working capital raises a point of concern. It is crucial for investors to monitor whether this is a temporary situation as a result of aggressive expansion or a sign of underlying issues in cash management. Capital expenditure remaining relatively flat suggests that the negative cash flow is not due to an increase in capital investments, which might be seen as a prudent approach during expansion phases.
OSI Systems' Security division's impressive 49% year-over-year revenue growth reflects a strong demand in the security sector, possibly driven by heightened global security concerns and technological advancements. The division's operating margin expansion to 22.1% from 14.7% indicates that OSI Systems is not only capturing greater market share but is doing so efficiently, with potential economies of scale coming into play.
The Optoelectronics and Manufacturing division's stable performance despite customer delays highlights resilience and adaptability, which are critical in managing supply chain disruptions. OSI Systems' decision to expand its manufacturing footprint into Mexico is strategically significant, potentially offering cost advantages and closer proximity to key markets.
The Healthcare division's weaker performance, amidst strong bookings, suggests that while there is demand for OSI's products, there may be operational or competitive challenges affecting revenue and income. This could be an area where the company needs to focus on innovation and competitive strategy to convert bookings into revenue more effectively.
The increase in OSI Systems' FY 2024 revenue guidance, from 18% to over 19%, alongside a non-GAAP adjusted diluted EPS growth projection from 27% to over 29%, indicates management confidence in the company's trajectory. This optimism may be underpinned by macroeconomic factors such as increased security spending, advancements in optoelectronics and potential recovery in healthcare expenditure post-pandemic.
However, it is important to consider the broader economic context. Inflationary pressures, supply chain issues, or geopolitical tensions could impact the company's costs, sales cycles and international operations. Investors should weigh these external factors against the company's internal strengths and risk mitigation strategies when considering the long-term outlook.
-
Record Q2 Revenues of
($373 Million 26% growth year-over-year) -
Record Q2 Earnings Per Diluted Share
-
GAAP EPS of
$2.11 -
Non-GAAP Adjusted EPS of
($2.21 86% growth year-over-year)
-
GAAP EPS of
-
Q2 Operating Income Growth of
105% Year-Over-Year -
Q2-Ended Backlog of Approximately
$1.8 Billion - Company Increases FY 2024 Revenue and Non-GAAP Adjusted Diluted EPS Guidance
Deepak Chopra, OSI Systems’ Chairman and Chief Executive Officer, stated “We are pleased to report a record-breaking second quarter for revenues and earnings, led by strong execution in the Security division and solid performance in the Optoelectronics and Manufacturing division. Given our robust backlog and high visibility into our pipeline of opportunities, we anticipate a strong second half of fiscal 2024.”
For Q2 FY24, the Company reported revenues of
For the six months ended December 31, 2023, revenues were
The Company's book-to-bill ratio was 1.0 for the second quarter of fiscal 2024. As of December 31, 2023, the Company's backlog was approximately
Mr. Chopra commented, “The Security division results reflect our tremendous momentum given increasing demand for our product and service offerings as well as our superior competitive position. Our revenues increased
Mr. Chopra continued, “Our Optoelectronics and Manufacturing division again delivered solid financial results with adjusted operating margin expansion on comparable year-over-year revenues as certain customers delayed the receipt of deliveries. This division continues to benefit from our vertically-integrated global manufacturing footprint, which further expanded into
Mr. Chopra concluded, “While general market conditions continued to pose challenges for our Healthcare division, and the division’s revenues and operating income decreased compared to the same quarter of the previous year, we are encouraged by the division’s strong bookings which generated a book-to-bill ratio over 1.1. We continue to focus on new product development, principally in our patient monitoring portfolio and anticipate stronger performance in the second half of the fiscal year compared to the first half of fiscal 2024.”
Fiscal Year 2024 Outlook
The Company is increasing its fiscal 2024 revenues guidance from anticipated growth in excess of
The Company’s fiscal 2024 adjusted diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for non-GAAP adjusted diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of non-GAAP adjusted diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control or cannot otherwise reasonably be predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the most directly comparable GAAP financial measure, being materially different from projected non-GAAP adjusted diluted EPS.
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income, non-GAAP adjusted diluted earnings per share, non-GAAP operating income (loss) by segment and non-GAAP operating margin, all of which are non-GAAP financial measures. The presentation of these non-GAAP figures for all fiscal periods is provided to allow for the comparison of the underlying performance of the Company, net of impairment, restructuring and other charges (including certain legal costs), amortization of intangible assets acquired through business acquisitions, non-cash interest expense, and their associated tax effects, and the impact of discrete income tax items. Although we exclude amortization of acquired intangible assets from our non-GAAP figures, revenue generated from such intangibles is included within revenue in determining non-GAAP financial performance of the Company. Management believes that the non-GAAP financial measures presented in this earnings release provide (i) enhanced insight into the ongoing operations of the Company, (ii) meaningful information regarding the Company’s financial results (excluding amounts management does not view as reflective of ongoing operating results) for purposes of planning, forecasting and assessing the performance of the Company’s businesses, (iii) a meaningful comparison of financial results of the current period against results of past periods and (iv) financial results that are generally more comparable to financial results of peer companies than are GAAP figures. Non-GAAP financial measures should not be assessed in isolation or as a substitute for measures of financial performance prepared in accordance with GAAP. These non-GAAP measures may not be the same as measures used by other companies due to possible differences in methods and in the items or events for which adjustments are made.
Reconciliations of GAAP financial information to non-GAAP financial information are provided in the accompanying tables. The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.
Conference Call Information
The Company will host a conference call and simultaneous webcast beginning at 9:00am PT (12:00pm ET) today to discuss its financial results for the periods presented in this earnings release. To listen, please visit the Investor Relations section of the OSI Systems website at http://investors.osi-systems.com/index.cfm and follow the link that will be posted on the front page. A replay of the webcast will be available beginning shortly after the conclusion of the conference call until February 8, 2024. The replay can be accessed through the Company’s website at www.osi-systems.com.
About OSI Systems
OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end-product markets. For more information on OSI Systems and its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-E
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company's current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside the Company's control and which may cause actual results to differ materially from those described in or implied by any forward-looking statement. Forward-looking statements include, but are not limited to, information provided regarding expected revenues, earnings, growth, and operational performance in fiscal 2024 and beyond. The Company could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; the impact of potential information technology, cybersecurity or data security breaches; changes in domestic and foreign government spending and budgetary, procurement and trade policies adverse to the Company's businesses; the impact of the
OSI SYSTEMS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) |
|||||||||||||||
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
||||||||||||
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
Revenues: |
|
|
|
|
|
|
|
||||||||
Products |
$ |
216,885 |
|
|
$ |
290,179 |
|
|
$ |
413,839 |
|
|
$ |
489,888 |
|
Services |
|
78,712 |
|
|
|
83,056 |
|
|
|
149,829 |
|
|
|
162,557 |
|
Total net revenues |
|
295,597 |
|
|
|
373,235 |
|
|
|
563,668 |
|
|
|
652,445 |
|
Cost of goods sold: |
|
|
|
|
|
|
|
||||||||
Products |
|
158,294 |
|
|
|
187,385 |
|
|
|
301,663 |
|
|
|
324,368 |
|
Services |
|
41,096 |
|
|
|
44,549 |
|
|
|
78,301 |
|
|
|
88,031 |
|
Total cost of goods sold |
|
199,390 |
|
|
|
231,934 |
|
|
|
379,964 |
|
|
|
412,399 |
|
Gross profit |
|
96,207 |
|
|
|
141,301 |
|
|
|
183,704 |
|
|
|
240,046 |
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative |
|
54,003 |
|
|
|
71,604 |
|
|
|
107,441 |
|
|
|
131,402 |
|
Research and development |
|
14,456 |
|
|
|
16,350 |
|
|
|
28,996 |
|
|
|
32,272 |
|
Restructuring and other charges, net |
|
2,257 |
|
|
|
1,026 |
|
|
|
3,476 |
|
|
|
1,492 |
|
Total operating expenses |
|
70,716 |
|
|
|
88,980 |
|
|
|
139,913 |
|
|
|
165,166 |
|
Income from operations |
|
25,491 |
|
|
|
52,321 |
|
|
|
43,791 |
|
|
|
74,880 |
|
Interest and other expense, net |
|
(5,180 |
) |
|
|
(6,534 |
) |
|
|
(8,612 |
) |
|
|
(12,282 |
) |
Income before income taxes |
|
20,311 |
|
|
|
45,787 |
|
|
|
35,179 |
|
|
|
62,598 |
|
Provision for income taxes |
|
(3,957 |
) |
|
|
(9,234 |
) |
|
|
(7,590 |
) |
|
|
(13,166 |
) |
Net income |
$ |
16,354 |
|
|
$ |
36,553 |
|
|
$ |
27,589 |
|
|
$ |
49,432 |
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings per share |
$ |
0.96 |
|
|
$ |
2.11 |
|
|
$ |
1.61 |
|
|
$ |
2.87 |
|
Weighted average shares outstanding – diluted |
|
17,103 |
|
|
|
17,302 |
|
|
|
17,140 |
|
|
|
17,238 |
|
UNAUDITED SEGMENT INFORMATION (in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Six Months Ended December 31, |
||||||||||||
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
Revenues – by Segment: |
|
|
|
|
|
|
|
||||||||
Security division |
$ |
167,444 |
|
|
$ |
249,975 |
|
|
$ |
312,436 |
|
|
$ |
414,604 |
|
Optoelectronics and Manufacturing division, including intersegment revenues |
|
98,709 |
|
|
|
98,097 |
|
|
|
192,625 |
|
|
|
194,225 |
|
Healthcare division |
|
43,520 |
|
|
|
41,850 |
|
|
|
87,083 |
|
|
|
79,637 |
|
Intersegment eliminations |
|
(14,076 |
) |
|
|
(16,687 |
) |
|
|
(28,476 |
) |
|
|
(36,021 |
) |
Total |
$ |
295,597 |
|
|
$ |
373,235 |
|
|
$ |
563,668 |
|
|
$ |
652,445 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) – by Segment: |
|
|
|
|
|
|
|
||||||||
Security division |
$ |
21,593 |
|
|
$ |
51,856 |
|
|
$ |
36,518 |
|
|
$ |
72,465 |
|
Optoelectronics and Manufacturing division |
|
12,212 |
|
|
|
11,621 |
|
|
|
23,470 |
|
|
|
23,058 |
|
Healthcare division |
|
1,404 |
|
|
|
429 |
|
|
|
3,032 |
|
|
|
593 |
|
Corporate |
|
(9,276 |
) |
|
|
(11,183 |
) |
|
|
(19,424 |
) |
|
|
(21,099 |
) |
Intersegment eliminations |
|
(442 |
) |
|
|
(402 |
) |
|
|
195 |
|
|
|
(137 |
) |
Total |
$ |
25,491 |
|
|
$ |
52,321 |
|
|
$ |
43,791 |
|
|
$ |
74,880 |
|
OSI SYSTEMS, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
|||||
|
June 30, 2023 |
|
December 31, 2023 |
||
Assets |
|
|
|
||
|
|
|
|
||
Cash and cash equivalents |
$ |
76,750 |
|
$ |
127,258 |
Accounts receivable, net |
|
380,845 |
|
|
370,168 |
Inventories |
|
338,008 |
|
|
445,818 |
Prepaid expenses and other current assets |
|
44,300 |
|
|
59,839 |
Total current assets |
|
839,903 |
|
|
1,003,083 |
Property and equipment, net |
|
108,933 |
|
|
110,188 |
Goodwill |
|
349,505 |
|
|
352,911 |
Intangible assets, net |
|
140,857 |
|
|
143,288 |
Other non-current assets |
|
116,488 |
|
|
117,007 |
Total Assets |
$ |
1,555,686 |
|
$ |
1,726,477 |
|
|
|
|
||
Liabilities and Stockholders' Equity |
|
|
|
||
|
|
|
|
||
Bank lines of credit |
$ |
215,000 |
|
$ |
316,000 |
Current portion of long-term debt |
|
8,076 |
|
|
8,120 |
Accounts payable and accrued expenses |
|
208,786 |
|
|
234,506 |
Other current liabilities |
|
139,832 |
|
|
141,765 |
Total current liabilities |
|
571,694 |
|
|
700,391 |
Long-term debt |
|
136,491 |
|
|
132,792 |
Other long-term liabilities |
|
121,336 |
|
|
122,851 |
Total liabilities |
|
829,521 |
|
|
956,034 |
Total stockholders’ equity |
|
726,165 |
|
|
770,443 |
Total Liabilities and Stockholders’ Equity |
$ |
1,555,686 |
|
$ |
1,726,477 |
RECONCILIATION OF GAAP TO NON-GAAP NET INCOME AND EARNINGS PER SHARE (in thousands, except earnings per share data) |
|||||||||||||||||||||||||||||||
|
Three Months Ended December 31, |
|
Six Months Ended December 31, |
||||||||||||||||||||||||||||
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
||||||||||||||||||||
|
Net income |
|
EPS |
|
Net income |
|
EPS |
|
Net income |
|
EPS |
|
Net income |
|
EPS |
||||||||||||||||
GAAP basis |
$ |
16,354 |
|
|
$ |
0.96 |
|
|
$ |
36,553 |
|
|
$ |
2.11 |
|
|
$ |
27,589 |
|
|
$ |
1.61 |
|
|
$ |
49,432 |
|
|
$ |
2.87 |
|
Restructuring and other charges, net |
|
2,257 |
|
|
|
0.13 |
|
|
|
1,026 |
|
|
|
0.06 |
|
|
|
3,476 |
|
|
|
0.20 |
|
|
|
1,492 |
|
|
|
0.09 |
|
Amortization of acquired intangible assets |
|
3,768 |
|
|
|
0.22 |
|
|
|
4,680 |
|
|
|
0.27 |
|
|
|
7,488 |
|
|
|
0.44 |
|
|
|
8,387 |
|
|
|
0.48 |
|
Non-cash interest expense |
|
139 |
|
|
|
0.01 |
|
|
|
- |
|
|
|
- |
|
|
|
295 |
|
|
|
0.02 |
|
|
|
- |
|
|
|
- |
|
Tax benefit of above adjustments |
|
(1,418 |
) |
|
|
(0.09 |
) |
|
|
(1,465 |
) |
|
|
(0.08 |
) |
|
|
(2,690 |
) |
|
|
(0.16 |
) |
|
|
(2,544 |
) |
|
|
(0.15 |
) |
Discrete tax benefit |
|
(716 |
) |
|
|
(0.04 |
) |
|
|
(2,540 |
) |
|
|
(0.15 |
) |
|
|
(814 |
) |
|
|
(0.05 |
) |
|
|
(2,953 |
) |
|
|
(0.17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Non-GAAP basis |
$ |
20,384 |
|
|
$ |
1.19 |
|
|
$ |
38,254 |
|
|
$ |
2.21 |
|
|
$ |
35,344 |
|
|
$ |
2.06 |
|
|
$ |
53,814 |
|
|
$ |
3.12 |
|
RECONCILIATION OF GAAP TO NON-GAAP
OPERATING INCOME (LOSS) AND OPERATING MARGIN BY SEGMENT (in thousands, except percentages) |
||||||||||||||||||||||||||||
Three Months Ended December 31, 2022 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Optoelectronics and Manufacturing Division |
|
Healthcare Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
|
$ |
21,593 |
|
12.9 |
% |
|
$ |
12,212 |
|
12.4 |
% |
|
$ |
1,404 |
|
3.2 |
% |
|
$ |
(9,718 |
) |
|
$ |
25,491 |
|
8.6 |
% |
Restructuring and other charges, net. |
|
|
77 |
|
0.0 |
% |
|
|
- |
|
- |
|
|
|
2,152 |
|
4.9 |
% |
|
|
28 |
|
|
|
2,257 |
|
0.8 |
% |
Amortization of acquired intangible assets |
|
|
2,883 |
|
1.8 |
% |
|
|
684 |
|
0.7 |
% |
|
|
201 |
|
0.5 |
% |
|
|
- |
|
|
|
3,768 |
|
1.3 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
24,553 |
|
14.7 |
% |
|
$ |
12,896 |
|
13.1 |
% |
|
$ |
3,757 |
|
8.6 |
% |
|
$ |
(9,690 |
) |
|
$ |
31,516 |
|
10.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Three Months Ended December 31, 2023 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Optoelectronics and Manufacturing Division |
|
Healthcare Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
|
$ |
51,856 |
|
20.7 |
% |
|
$ |
11,621 |
|
11.8 |
% |
|
$ |
429 |
|
1.0 |
% |
|
$ |
(11,585 |
) |
|
$ |
52,321 |
|
14.0 |
% |
Restructuring and other charges, net. |
|
|
164 |
|
0.1 |
% |
|
|
525 |
|
0.5 |
% |
|
|
- |
|
- |
|
|
|
337 |
|
|
|
1,026 |
|
0.3 |
% |
Amortization of acquired intangible assets |
|
|
3,339 |
|
1.3 |
% |
|
|
1,039 |
|
1.1 |
% |
|
|
302 |
|
0.7 |
% |
|
|
- |
|
|
|
4,680 |
|
1.2 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
55,359 |
|
22.1 |
% |
|
$ |
13,185 |
|
13.4 |
% |
|
$ |
731 |
|
1.7 |
% |
|
$ |
(11,248 |
) |
|
$ |
58,027 |
|
15.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, 2022 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Optoelectronics and Manufacturing Division |
|
Healthcare Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
|
$ |
36,518 |
|
11.7 |
% |
|
$ |
23,470 |
|
12.2 |
% |
|
$ |
3,032 |
|
3.5 |
% |
|
$ |
(19,229 |
) |
|
$ |
43,791 |
|
7.8 |
% |
Restructuring and other charges, net. |
|
|
865 |
|
0.3 |
% |
|
|
15 |
|
0.0 |
% |
|
|
2,446 |
|
2.8 |
% |
|
|
150 |
|
|
|
3,476 |
|
0.6 |
% |
Amortization of acquired intangible assets |
|
|
5,703 |
|
1.8 |
% |
|
|
1,382 |
|
0.7 |
% |
|
|
403 |
|
0.5 |
% |
|
|
- |
|
|
|
7,488 |
|
1.3 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
43,086 |
|
13.8 |
% |
|
$ |
24,867 |
|
12.9 |
% |
|
$ |
5,881 |
|
6.8 |
% |
|
$ |
(19,079 |
) |
|
$ |
54,755 |
|
9.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Six Months Ended December 31, 2023 |
||||||||||||||||||||||||||||
|
|
Security Division |
|
Optoelectronics and Manufacturing Division |
|
Healthcare Division |
|
Corporate / Elimination |
|
Total |
||||||||||||||||||
|
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
% of Sales |
|
|
|
|
|
% of Sales |
||||||||||
GAAP basis – operating income (loss) |
|
$ |
72,465 |
|
17.5 |
% |
|
$ |
23,058 |
|
11.9 |
% |
|
$ |
593 |
|
0.7 |
% |
|
$ |
(21,236 |
) |
|
$ |
74,880 |
|
11.5 |
% |
Restructuring and other charges, net. |
|
|
436 |
|
0.1 |
% |
|
|
576 |
|
0.3 |
% |
|
|
- |
|
0.0 |
% |
|
|
480 |
|
|
|
1,492 |
|
0.2 |
% |
Amortization of acquired intangible assets |
|
|
5,966 |
|
1.4 |
% |
|
|
1,818 |
|
0.9 |
% |
|
|
603 |
|
0.8 |
% |
|
|
- |
|
|
|
8,387 |
|
1.3 |
% |
Non-GAAP basis– operating income (loss) |
|
$ |
78,867 |
|
19.0 |
% |
|
$ |
25,452 |
|
13.1 |
% |
|
$ |
1,196 |
|
1.5 |
% |
|
$ |
(20,756 |
) |
|
$ |
84,759 |
|
13.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20240125956498/en/
For Additional Information, Contact:
OSI Systems, Inc.
Ajay Vashishat
Vice President, Business Development
Tel: (310) 349-2237
avashishat@osi-systems.com
Source: OSI Systems, Inc.
FAQ
What are OSI Systems, Inc.'s record Q2 revenues?
What is the company's ticker symbol?
What is the Q2 earnings per diluted share GAAP EPS?
What is the non-GAAP adjusted EPS for Q2?
What is the Q2-Ended backlog for OSI Systems, Inc.?